|
| Cynomolgus EPHA2 Protein (LTP10069) |
|
| LTP10069 |
|
| 100ug |
|
|
$473 In stock |
| Ephrin type-A receptor 2 (EPHA2) is a receptor tyrosine kinase (RTK), whose over-expression has been observed in a variety of cancers, including breast cancer. EPHA2 expression may be causally related to tumorigenesis; therefore, it is important to understand how EPHA2 gene (EPHA2) expression is regulated. |
| Recombinant Cynomolgus EPHA2 Protein is expressed from Expi293 with hFc tag at the C-terminal. It contains Ala24-Ser534. |
|
| EPHA2 |
|
| Cynomolgus |
|
| Q1KL86 |
|
| Ala24-Ser534 |
|
| The protein has a predicted MW of 83.1 kDa. Due to glycosylation, the protein migrates to 90-100 kDa based on the Tris-Bis PAGE result. |
|
| 0 |
|
| C-hFc |
|
| Expi293 |
|
| > 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC |
|
| Less than 1EU per ug by the LAL method. |
|
| Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as a protectant before lyophilization. |
|
| Reconstituted protein stable at -80 C for 12 months, 4 C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
|
| Shipped at ambient temperature. |
|
| Centrifuge tubes before opening. Reconstituting to a concentration of more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water. |
|
|  |
